Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases
- PMID: 11767404
- DOI: 10.1080/10715760100301471
Interactions of nitric oxide-derived reactive nitrogen species with peroxidases and lipoxygenases
Abstract
Nitric oxide (NO) is a major free radical modulator of smooth muscle tone, which under basal conditions acts to preserve vascular homeostasis through its anti-inflammatory properties. The biochemistry of NO, in particular, its rapid conversion in vivo into secondary reactive nitrogen species (RNS), its chemical nature as a free radical and its high diffusibility and hydrophobicity dictate that this species will interact with numerous biomolecules and enzymes. In this review, we consider the interactions of a number of enzymes found in the vasculature with NO and NO-derived RNS. All these enzymes are either homeostatic or promote the development of atherosclerosis and hypertension. Therefore their interactions with NO and NO-derived RNS will be of central importance in the initiation and progression of vascular disease. In some examples, (e.g. lipoxygenase, LOX), such interactions provide catalytic 'sinks' for NO, but for others, in particular peroxidases and prostaglandin H synthase (PGHS), reactions with NO may be detrimental. Nitric oxide and NO-derived RNS directly modulate the activity of vascular peroxidases and LOXs through a combination of effects, including transcriptional regulation, altering substrate availability, and direct reaction with enzyme turnover intermediates. Therefore, these interactions will have two major consequences: (i) depletion of NO levels available to cause vasorelaxation and prevent leukocyte/platelet adhesion and (ii) modulation of activity of the target enzymes, thereby altering the generation of bioactive signaling molecules involved in maintenance of vascular homeostasis, including prostaglandins and leukotrienes.
Similar articles
-
Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis.FASEB J. 1999 Jul;13(10):1121-36. doi: 10.1096/fasebj.13.10.1121. FASEB J. 1999. PMID: 10385604 Review.
-
Oxidases and oxygenases in regulation of vascular nitric oxide signaling and inflammatory responses.Immunol Res. 2002;26(1-3):107-18. doi: 10.1385/IR:26:1-3:107. Immunol Res. 2002. PMID: 12403350 Review.
-
Depletion of iNOS-derived nitric oxide by prostaglandin H synthase-2 in inflammation-activated J774.2 macrophages through lipohydroperoxidase turnover.Biochem J. 2005 Feb 1;385(Pt 3):815-21. doi: 10.1042/BJ20041353. Biochem J. 2005. PMID: 15461587 Free PMC article.
-
Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease.Circ Res. 2001 Jan 19;88(1):12-21. doi: 10.1161/01.res.88.1.12. Circ Res. 2001. PMID: 11139468 Review.
-
Nitric oxide insufficiency and atherothrombosis.Histochem Cell Biol. 2004 Oct;122(4):353-67. doi: 10.1007/s00418-004-0675-z. Epub 2004 Aug 26. Histochem Cell Biol. 2004. PMID: 15338226 Review.
Cited by
-
Inhibition of pacemaker activity in interstitial cells of Cajal by LPS via NF-κB and MAP kinase.World J Gastroenterol. 2013 Feb 28;19(8):1210-8. doi: 10.3748/wjg.v19.i8.1210. World J Gastroenterol. 2013. PMID: 23482668 Free PMC article.
-
The relationship of redox signaling with the risk for atherosclerosis.Front Pharmacol. 2024 Aug 1;15:1430293. doi: 10.3389/fphar.2024.1430293. eCollection 2024. Front Pharmacol. 2024. PMID: 39148537 Free PMC article. Review.
-
Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors.Blood. 2006 Dec 15;108(13):4059-62. doi: 10.1182/blood-2006-02-005330. Epub 2006 Aug 24. Blood. 2006. PMID: 16931629 Free PMC article.
-
Specific mediator inhibition by the NO donors SNP and NCX 2057 in the peripheral lung: implications for allergen-induced bronchoconstriction.Respir Res. 2009 Jun 4;10(1):46. doi: 10.1186/1465-9921-10-46. Respir Res. 2009. PMID: 19493362 Free PMC article.
-
Redox homeostasis in mycobacteria: the key to tuberculosis control?Expert Rev Mol Med. 2011 Dec 16;13:e39. doi: 10.1017/S1462399411002079. Expert Rev Mol Med. 2011. PMID: 22172201 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources